Edoxaban Enhances Thromboprophylaxis by Physiotherapy After Total Knee Arthroplasty ― The Randomized Controlled ESCORT-TKA Trial ―
-
- Sueta Daisuke
- Department of Cardiovascular Medicine, Faculty of Life Sciences, Kumamoto University
-
- Kaikita Koichi
- Department of Cardiovascular Medicine, Faculty of Life Sciences, Kumamoto University
-
- Okamoto Nobukazu
- Department of Orthopaedic Surgery, Faculty of Life Sciences, Kumamoto University
-
- Yamabe Soichiro
- Department of Orthopaedic Surgery, Faculty of Life Sciences, Kumamoto University
-
- Ishii Masanobu
- Department of Cardiovascular Medicine, Faculty of Life Sciences, Kumamoto University
-
- Arima Yuichiro
- Department of Cardiovascular Medicine, Faculty of Life Sciences, Kumamoto University
-
- Ito Miwa
- Department of Cardiovascular Medicine, Faculty of Life Sciences, Kumamoto University
-
- Oimatsu Yu
- Department of Cardiovascular Medicine, Faculty of Life Sciences, Kumamoto University
-
- Mitsuse Tatsuro
- Department of Cardiovascular Medicine, Faculty of Life Sciences, Kumamoto University
-
- Iwashita Satomi
- Department of Cardiovascular Medicine, Faculty of Life Sciences, Kumamoto University
-
- Nakamura Eiichi
- Department of Orthopaedic Surgery, Faculty of Life Sciences, Kumamoto University
-
- Hokimoto Seiji
- Department of Cardiovascular Medicine, Faculty of Life Sciences, Kumamoto University
-
- Mizuta Hiroshi
- Department of Orthopaedic Surgery, Faculty of Life Sciences, Kumamoto University
-
- Ogawa Hisao
- Department of Cardiovascular Medicine, Faculty of Life Sciences, Kumamoto University
-
- Tsujita Kenichi
- Department of Cardiovascular Medicine, Faculty of Life Sciences, Kumamoto University
この論文をさがす
説明
<p>Background:The pharmacological advantage of combining physiotherapy with anticoagulants for the prevention of venous thromboembolism (VTE) after total knee arthroplasty (TKA) is not fully known. Herein we investigated the potential benefit of this combination therapy in patients undergoing TKA.</p><p>Methods and Results:The 38 patients were randomly assigned to a physiotherapy group (n=19) or a physiotherapy plus 30 mg/day edoxaban group (n=19). The occurrence of VTE was evaluated, as were serial changes in parameters measured by the Total Thrombus-formation Analysis System, a novel system for quantitatively analyzing thrombus formation using microchips with thrombogenic surfaces (collagen plus tissue factor, atheroma [AR]-chip). Combination therapy significantly reduced the incidence of VTE after TKA compared with monotherapy (P=0.038). The area under the curve (AUC) of thrombus formation for the AR-chip (AR10-AUC30) was significantly lower in the combination group (P=0.001) on Day 7 after TKA than before TKA, but no significant change was observed with monotherapy (P=0.809). In 13 VTE-positive patients, AR10-AUC30was significantly lower in the combination group (n=3) than in the monotherapy group (n=10) on Day 7 (P=0.045).</p><p>Conclusions:The combination of physiotherapy and edoxaban significantly reduced the incidence of VTE after TKA compared with physiotherapy alone. However, it is possible that VTE occurrence after TKA is not only associated with thrombogenicity, but also rheological factors.</p>
収録刊行物
-
- Circulation Journal
-
Circulation Journal 82 (2), 524-531, 2018
一般社団法人 日本循環器学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390001205106182656
-
- NII論文ID
- 130006321860
-
- NII書誌ID
- AA11591968
-
- ISSN
- 13474820
- 13469843
-
- NDL書誌ID
- 028782356
-
- PubMed
- 28924075
-
- 本文言語コード
- en
-
- 資料種別
- journal article
-
- データソース種別
-
- JaLC
- NDLサーチ
- Crossref
- PubMed
- CiNii Articles
- KAKEN
- OpenAIRE
-
- 抄録ライセンスフラグ
- 使用不可